New approaches to the selective transport of antineoplastic agents: cell physiology and nanotechnology
Severin, E.S.; Posypanova, G.A.
Fiziolohichnyi Zhurnal 57(5): 73-74
2011
ISSN/ISBN: 2522-9028 PMID: 22276313 Document Number: 655399
Document emailed within 1 workday
Related Documents
Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839Kawabata, M.; Hosokawa, H.; Katoh, K.; Izumi, R. 1987: Sensitivity of antineoplastic agents in squamous cell carcinoma of the uterine cervix xenografted into nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3058-3063
Hamasaki, N.; Harasaki, H.; Tomoda, A.; Minakami, S. 1977: Uphill and selective transport of phosphoenolpyruvate through red cell membrane Acta Biologica et Medica Germanica 36(5-6): 913-918
Mashiba, H.; Kanaya, S. 1974: Actions of anti-arrhythmic agents on physiology of myocardial cell membrane Nihon Rinsho. Japanese Journal of Clinical Medicine 32(9): 2829-2834
Kolassa, N. 1980: Membrane transport of antineoplastic drugs and its relevance to tumour chemotherapy Wiener Klinische Wochenschrift 92(20): 707-715
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
1971: Chemistry of antineoplastic agents Minerva Medica 62(28): 1492
Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
Berti, T. 1970: Specific histotropism of antineoplastic agents La Clinica Terapeutica 55(4): 293-303
Wada, T.; Matsui, H. 2013: Research development of novel antineoplastic agents Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Suwa, K. 1974: Physiology of oxygen transport Masui. Japanese Journal of Anesthesiology 23(8): 693-699
Babaian, I.S.; Khudaverdian, N.V.; Karapetian, L.G.; Kazarian, R.S.; Sogomonian, L.R. 1997: Comparative study of three antineoplastic alkylating agents on DNA Biofizika 42(2): 542-543
Orfi, L.; Wáczek, F.; Szabó, M.; Kövesdi, I.; Mészáros, G.; Idei, M.; Horváth, A.; Hollósy, F.; Mák, M.; Szegedi, Z.; Szende, B.; Kéri, G.; Noszál, B. 1999: Preparation and characterization of potential antineoplastic agents Acta Pharmaceutica Hungarica 69(3): 115-122
Matsumura, Y. 1982: Intravesical instillation of adriamycin and other antineoplastic agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 372-376
Le Guern, M. 1987: DNA-topoisomerase II: Cellular targets of antineoplastic agents Pathologie-Biologie 35(4): 343-345
Sakurai, Y. 1975: Deveolpment of new antineoplastic agents and their clinical characteristics Nihon Rinsho. Japanese Journal of Clinical Medicine 33(5): 1892-1896
Schmoll, H.J.; Hiddemann, W.; Rustum, Y.; Köhne-Wömpner, C.H. 1992: The emerging role for biomodulation of antineoplastic agents Seminars in Oncology 19(2 Suppl 3: 1-3
Takeuchi, A. 1980: Bronchial artery infusion of antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 38(7): 2683-2690